Global Pharmaceutical Excipients Market (By Chemistry Type- Animal based, Plant Based, Mineral, and Synthetic. By Product Type- Fatty Alcohols, Glycerin, Sugar Alcohols, Starch, and Others. By Formulation Type- Oral, Parenteral, and Others. By Functionality- Binders, Glidants, Disintegrant, and Others)– Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025
The report covers the analysis and forecast of the pharmaceutical excipients market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).
The study provides a detailed view of the pharmaceutical excipients market, by segmenting it based on by chemistry type, product type, formulation type, functionality and regional demand. Robust growth of pharmaceutical products and increasing geriatric population in the past several years have propelled the demand for the pharmaceutical excipients market. Moreover, wide usage of innovative drug delivery is another prime factor driving the market demand. Additionally, research and development for producing new products is one of the most important factors which will rise the demand of this market.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by chemistry type, product type, formulation type, functionality in all regions. These include different business strategies adopted by the leading players and their recent developments.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the pharmaceutical excipients market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the pharmaceutical excipients market.
The report provides the size of the pharmaceutical excipients market in 2017 and the forecast for the next eight years up to 2025. The size of the global pharmaceutical excipients market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The pharmaceutical excipients market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the pharmaceutical excipients market, split into regions. Based on chemistry type, product type, formulation type, and functionality the individual revenues from all the regions is summed up to achieve the global revenue for pharmaceutical excipients. Companies were considered for the market share analysis, based on their innovation and revenue generation. In the absence of specific data related to the sales of pharmaceutical excipients several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Adnagen AG, Aviva Biosciences, Biocep Ltd., Biofluidica Microtechnologies LLC, Evonik Industries AG, FMC Corporation, Innophos Holdings Inc., The Lubrizol Corporation, and Roquette Group.
The global pharmaceutical excipients market has been segmented into:
Global Pharmaceutical Excipients Market: By Chemistry Type
The study provides a detailed view of the pharmaceutical excipients market, by segmenting it based on by chemistry type, product type, formulation type, functionality and regional demand. Robust growth of pharmaceutical products and increasing geriatric population in the past several years have propelled the demand for the pharmaceutical excipients market. Moreover, wide usage of innovative drug delivery is another prime factor driving the market demand. Additionally, research and development for producing new products is one of the most important factors which will rise the demand of this market.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by chemistry type, product type, formulation type, functionality in all regions. These include different business strategies adopted by the leading players and their recent developments.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the pharmaceutical excipients market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the pharmaceutical excipients market.
The report provides the size of the pharmaceutical excipients market in 2017 and the forecast for the next eight years up to 2025. The size of the global pharmaceutical excipients market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The pharmaceutical excipients market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the pharmaceutical excipients market, split into regions. Based on chemistry type, product type, formulation type, and functionality the individual revenues from all the regions is summed up to achieve the global revenue for pharmaceutical excipients. Companies were considered for the market share analysis, based on their innovation and revenue generation. In the absence of specific data related to the sales of pharmaceutical excipients several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Adnagen AG, Aviva Biosciences, Biocep Ltd., Biofluidica Microtechnologies LLC, Evonik Industries AG, FMC Corporation, Innophos Holdings Inc., The Lubrizol Corporation, and Roquette Group.
The global pharmaceutical excipients market has been segmented into:
Global Pharmaceutical Excipients Market: By Chemistry Type
- Animal based
- Plant based
- Mineral
- Synthetic
- Fatty alcohols
- Glycerin
- Sugar alcohols
- Starch
- Others
- Oral
- Parenteral
- others
- Binders
- Glidants
- Disintegrant
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Rest of Asia Pacific
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Rest of Latin America
1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS
2 EXECUTIVE SUMMARY
2.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW- BY CHEMISTRY TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY CHEMISTRY TYPE
4.1.1.1 ANIMAL BASED
4.1.1.2 PLANT BASED
4.1.1.3 MINERAL
4.1.1.4 SYNTHETIC
5 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE
5.1.1.1 FATTY ALCOHOLS
5.1.1.2 GLYCERIN
5.1.1.3 SUGAR ALCOHOLS
5.1.1.4 STARCH
5.1.1.5 OTHERS
6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY FORMULATION TYPE
6.1 INTRODUCTION
6.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY FORMULATION TYPE
6.1.1.1 ORAL
6.1.1.2 PARENTERAL
6.1.1.3 OTHERS
7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY FUNCTIONALITY
7.1 INTRODUCTION
7.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY FUNCTIONALITY
7.1.1.1 BINDERS
7.1.1.2 GLIDANTS
7.1.1.3 DISINTEGRANT
7.1.1.4 OTHERS
8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
8.1 INTRODUCTION
8.2 KEY TAKEWAYS
9 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
9.3 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
9.4 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
9.5 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
9.6 U.S.
9.7 CANADA
9.8 MEXICO
10 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
10.3 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
10.4 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
10.5 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
10.6 U.K.
10.7 FRANCE
10.8 GERMANY
10.9 ITALY
10.10 SPAIN
10.11 REST OF EUROPE
11 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
11.3 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
11.4 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
11.5 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
11.6 INDIA
11.7 CHINA
11.8 JAPAN
11.9 REST OF ASIA PACIFIC
12 MIDDLE EAST AND AFRICA (MEA) PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
12.3 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
12.4 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
12.5 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
12.6 SOUTH AFRICA
12.7 REST OF MIDDLE EAST AND AFRICA
13 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
13.1 MARKET DYNAMICS
13.1.1 DRIVERS
13.1.2 RESTRAINTS
13.1.3 OPPORTUNITIES
13.2 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
13.3 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
13.4 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
13.5 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
13.6 BRAZIL
13.7 REST OF LATIN AMERICA
14 COMPETATIVE LANDSCAPE
14.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET-COMPANY MARKET SHARE ANALYSIS
15 COMPANY PROFILES: (REVENUE, CHEMISTRY TYPES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
15.1 ADNAGEN AG
15.2 AVIVA BIOSCIENCES
15.3 BIOCEP LTD.
15.4 BIOFLUIDICA MICROTECHNOLOGIES LLC
15.5 EVONIK INDUSTRIES AG
15.6 FMC CORPORATION
15.7 INNOPHOS HOLDINGS INC.
15.8 THE LUBRIZOL CORPORATION
15.9 ROQUETTE GROUP
15.10 SIGNET
2 EXECUTIVE SUMMARY
2.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW- BY CHEMISTRY TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY CHEMISTRY TYPE
4.1.1.1 ANIMAL BASED
4.1.1.2 PLANT BASED
4.1.1.3 MINERAL
4.1.1.4 SYNTHETIC
5 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE
5.1.1.1 FATTY ALCOHOLS
5.1.1.2 GLYCERIN
5.1.1.3 SUGAR ALCOHOLS
5.1.1.4 STARCH
5.1.1.5 OTHERS
6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY FORMULATION TYPE
6.1 INTRODUCTION
6.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY FORMULATION TYPE
6.1.1.1 ORAL
6.1.1.2 PARENTERAL
6.1.1.3 OTHERS
7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS AND FORECAST, BY FUNCTIONALITY
7.1 INTRODUCTION
7.1.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY FUNCTIONALITY
7.1.1.1 BINDERS
7.1.1.2 GLIDANTS
7.1.1.3 DISINTEGRANT
7.1.1.4 OTHERS
8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
8.1 INTRODUCTION
8.2 KEY TAKEWAYS
9 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
9.3 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
9.4 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
9.5 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
9.6 U.S.
9.7 CANADA
9.8 MEXICO
10 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
10.3 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
10.4 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
10.5 EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
10.6 U.K.
10.7 FRANCE
10.8 GERMANY
10.9 ITALY
10.10 SPAIN
10.11 REST OF EUROPE
11 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
11.3 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
11.4 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
11.5 ASIA PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
11.6 INDIA
11.7 CHINA
11.8 JAPAN
11.9 REST OF ASIA PACIFIC
12 MIDDLE EAST AND AFRICA (MEA) PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
12.3 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
12.4 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
12.5 MEA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
12.6 SOUTH AFRICA
12.7 REST OF MIDDLE EAST AND AFRICA
13 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
13.1 MARKET DYNAMICS
13.1.1 DRIVERS
13.1.2 RESTRAINTS
13.1.3 OPPORTUNITIES
13.2 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY CHEMISTRY TYPE
13.3 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY PRODUCT TYPE
13.4 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FORMULATION TYPE
13.5 LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS- BY FUNCTIONALITY
13.6 BRAZIL
13.7 REST OF LATIN AMERICA
14 COMPETATIVE LANDSCAPE
14.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET-COMPANY MARKET SHARE ANALYSIS
15 COMPANY PROFILES: (REVENUE, CHEMISTRY TYPES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
15.1 ADNAGEN AG
15.2 AVIVA BIOSCIENCES
15.3 BIOCEP LTD.
15.4 BIOFLUIDICA MICROTECHNOLOGIES LLC
15.5 EVONIK INDUSTRIES AG
15.6 FMC CORPORATION
15.7 INNOPHOS HOLDINGS INC.
15.8 THE LUBRIZOL CORPORATION
15.9 ROQUETTE GROUP
15.10 SIGNET
